symbicort

01/01/2009 - "Symbicort SMART delivers improved asthma outcomes with lower treatment and social costs than any alternative."
01/01/2009 - "Current control of asthma symptoms is improved or achieved with reduced total dose administration with Symbicort SMART compared with any reasonable alternate option. "
06/01/2014 - "This is a cross-sectional, multicentre study involving adult patients with persistent asthma who were prescribed only Symbicort SMART in the preceding one month prior to recruitment. "
06/01/2014 - "Satisfaction level and asthma control among Malaysian asthma patients on Symbicort Maintenance and Reliever Therapy (SMART) in the primary care setting (SMARTEST study)."
06/01/2014 - "Symbicort SMART resulted in a high satisfaction level and asthma control among Malaysian patients treated in the primary care setting and it is an effective and appealing treatment for asthmatic patients."

06/01/2007 - "The positive results with Symbicort SMART can be explained by the early as-needed use on the inhaled corticosteroid component, which puts out the early flames of inflammation, together with the interaction between the beta(2)-agonist, formoterol, and the inhaled corticosteroid, budesonide."

01/01/2008 - "In COPD, Symbicort offers clinical advantages over therapy with the monocomponents and these are achieved at little or no extra cost."
01/01/2008 - "A total of 13 studies on Symbicort in asthma and 2 studies on Symbicort in COPD were found. "
03/01/2004 - "Are Seretide and Symbicort useful in COPD?"
10/01/2014 - "Inspiratory flow parameters via EH and Symbicort(®) Turbuhaler(®) (TH) inhalers were evaluated in 187 patients with asthma and COPD. "
12/01/2012 - "This study investigated the rapid onset of bronchodilation effect and compared lung function changes following budesonide/formoterol (Symbicort Turbuhaler®) inhalation in Chinese patients with moderate-severe chronic obstructive pulmonary disease (COPD) and bronchial asthma. "

04/01/2008 - "We also investigated the effect of treatment with budesonide/formoterol (Symbicort; AstraZeneca, Lund, Sweden) in the relationship between VEGF and airway remodelling. "